CoreMap
PrivateLast Round
Series C
Jul 29, 2026
Est. Valuation
$180.05M
Total Funding Raised
$70.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CoreMap is a medical device company that develops a diagnostic technology platform to identify the drivers of complex cardiac arrhythmias, such as atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoreMap Comparables
Compare CoreMap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnChannel Medical | 86% | |
| Cortex | 85% | |
| Cortex, Inc. | 81% |
CoreMap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 29, 2026 | ||||
| Early Stage VC | Jun 24, 2026 | ||||
| Series B | Feb 9, 2022 | ||||
| Series A Extension | Feb 9, 2022 | ||||
| Series A | Sep 17, 2020 | ||||
Grant | Sep 8, 2020 |
CoreMap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| America's Seed Fund | Grant |
| UVM Ventures | Series A |
| National Science Foundation | Grant |
| Qure Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 16, 2.3x the trailing average.
- Jul 29, 2026
$37M round led by Medtronic
Recent news
Latest coverage and updates
- receives_financingJul 31, 2026
CoreMap Inc. received financing of $37M in Series C on Jul 31st '26.
- is_developingJul 31, 2026
CoreMap Inc. is developing advanced electrophysiology mapping system on Jul 31st '26.
- is_developingJul 31, 2026
CoreMap Inc. is planning to develop data-driven tools to assist atrial fibrillation ablation.
CoreMap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CoreMap's valuation, stock price, and market status.
Is CoreMap a public or private company?
CoreMap is a private company.
What is the current stock price of CoreMap?
CoreMap is a private company with no public stock price. No recent secondary market data is available.
How much is CoreMap worth (valuation)?
Valuation information for CoreMap is not publicly available.
Can I buy CoreMap stock?
CoreMap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CoreMap's last funding round?
CoreMap's most recent funding round was Early Stage VC on June 24, 2026.
Who are the main investors in CoreMap?
Key investors in CoreMap include Qure Ventures.
Will CoreMap IPO soon?
No public IPO plans have been announced for CoreMap.
How can I track CoreMap secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoreMap's secondary market activity and sign up for updates.